The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity	Embolism, Embolism and Thrombosis, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Hemorrhage, Obstetric Labor Complications, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postpartum Hemorrhage, Thromboembolism, Urogenital Diseases, Uterine Hemorrhage, Venous Thrombosis, cardiovascular disorder, hematologic disorder, hypertension, pregnancy-induced, lung disorder, preeclampsia, pregnancy disorder, puerperal disorder, pulmonary embolism, respiratory system disorder, thrombophilia, thrombotic disease, vascular disorder, venous thromboembolism	Recruiting	Phase 3	2026-07-27		NCT06494878

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Canadian Institutes of Health Research (CIHR)	339
European Clinical Research Infrastructure Network	6
University of Calgary	238

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Amsterdam UMC	Amsterdam	Netherlands	6
APHP - Hôpital Port Royal	Paris	France	1
Association Hospitalière De Bruxelles Et De Schaerbeek - Centre Hospitalier Universitaire Brugmann	Brussels	Belgium	1
CHU de Nancy	Nancy	France	3
CHU de Saint-Etienne	Saint-Etienne	France	37
Chu de Toulouse	Toulouse	France	20
Foothills Medical Centre	Calgary	Canada	20
Hvidovre Hospital	Hvidovre	Denmark	1
Medical University of Warsaw	Warsaw	Poland	7
Rotunda Hospital, RCSI Department of Obstetrics and Gynaecology	Dublin	Ireland	1
The Ottawa Hospital - General Campus	Ottawa	Canada	31
UCD Centre for Human Reproduction, The Coombe Hospital	Dublin	Ireland	1